Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease

Overview of attention for article published in Journal of Inherited Metabolic Disease, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 4,645 followers.

RT @JIMD_Editors: Trials of triheptanoin aren’t new, in 2013 Francis et al looked at its use in the nur7 mouse model of Canavan Disease. Th…

02 Dec 2019

Reply Repost Favourite

RT @JIMD_Editors: Trials of triheptanoin aren’t new, in 2013 Francis et al looked at its use in the nur7 mouse model of Canavan Disease. Th…

02 Dec 2019

Reply Repost Favourite

Trials of triheptanoin aren’t new, in 2013 Francis et al looked at its use in the nur7 mouse model of Canavan Disease. They found that it rescued oligodendrocyte loss, dysmyelination and motor function https://t.co/7ggzBGGK9d https://t.co/9vYuDG5i0k

02 Dec 2019

Reply Repost Favourite